MyFinsight
Home
About
Contact
mrvi: the income statement
Download
Download image
Net loss
attributable to maravai...
-$25,556K
(74.20%↑ Y/Y)
Net loss
attributable to...
-$19,501K
(74.65%↑ Y/Y)
Biologics Safety Testing
Segment
$237K
Nucleic Acid Production
Segment
$59K
Biologics Safety Testing
Segment
$4,642K
Nucleic Acid Production
Segment
$3,697K
Biologics Safety Testing
Segment
$4,059K
Nucleic Acid Production
Segment
$3,910K
Biologics Safety Testing
Segment
$7,339K
Nucleic Acid Production
Segment
$17,687K
Net loss
-$45,057K
(74.39%↑ Y/Y)
Income tax (benefit)
expense
-$92K
(-129.58%↓ Y/Y)
Latin And Central
America
$296K
Asia Pacific
$8,339K
EMEA
$7,969K
North America
$25,026K
Loss before income
taxes
-$45,149K
(74.30%↑ Y/Y)
Interest income
$2,797K
(-60.44%↓ Y/Y)
Revenue
$41,630K
(-36.15%↓ Y/Y)
Other (expense)
income
-$71K
(-198.61%↓ Y/Y)
Interest expense
$6,844K
(-49.80%↓ Y/Y)
Loss from operations
-$41,031K
(75.74%↑ Y/Y)
Gross profit
$5,655K
Cost of revenue
$35,975K
(-2.31%↓ Y/Y)
Total operating
expenses
$46,686K
(-80.08%↓ Y/Y)
Restructuring
$7,386K
(184750.00%↑ Y/Y)
Change in estimated
fair value of...
$60K
(133.71%↑ Y/Y)
Research and development
$3,844K
(-11.51%↓ Y/Y)
Selling, general and
administrative
$35,396K
(-9.44%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)